Haiti: Death Rate From HIV Falls 75 Percent With Early Treatment, Study Finds
July 19, 2010
Early initiation of antiretroviral (ARV) therapy decreased mortality rates and TB incidence among Haitian patients, according to a new study. "Access to antiretroviral therapy should be expanded to include all HIV-infected adults who have CD4+ T-cell counts of less than 350 per cubic millimeter, including those who live in areas with limited resources," wrote Dr. Daniel W. Fitzgerald, of Weill Cornell Medical School in New York, and colleagues.
The open-label study lasted from 2005 to 2008 and involved 816 HIV patients with CD4+ T-cell counts greater than 200/mm3 and less than 350 (median=280/mm3). The patients were randomized into either an early-treatment group, initiating ARVs two weeks after enrollment, or a standard-treatment group, beginning ARVs when their CD4+ T-cell count fell to 200 or lower or when clinical AIDS developed. Both groups received zidovudine, lamivudine, and efavirenz upon initiating treatment and underwent monthly follow-up.
07.14.2010; Kristine Aquino, Bloomberg News
This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. Visit the CDC's website to find out more about their activities, publications and services.
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)